Blog
Global
  • Horus Pharma IBERICAEspagne/Spain
  • Horus Pharma BELGIQUEBelgique/Belgium
  • Horus Pharma NEDERLANDPays-Bas/The Netherlands
  • Horus Pharma SWITZERLANDSuisse/Switzerland
fr Français
gb English
Horus Pharma
  • logo
  • About
    • Corporate Social Responsibility
    • Expertise
    • History
    • Values and commitment
    • Team
    • Key Figures
    • Other site
    • Videos
  • Products
    Ophthalmology Ophthalmology
    • Allergy
    • Healing
    • Glaucome
    • Herpes
    • Infection
    • Sore
    • Corneal edema
    • Diabetic macular edema
    • Tissue regeneration
    • Ocular dryness
    Micronutrition Micronutrition
    • Food supplements
    > See the site
    Micronutrition
    • Food supplements
    Dermatology Dermatology
    • Blepharitis, meibomian gland dysfonction
    Dermatology
    • Blepharitis, meibomian gland dysfonction
    Contactology Contactology
    • Rigid lenses care
    • Soft contact lenses care
    Contactology
    • Rigid lenses care
    • Soft contact lenses care
    Surgery Surgery
    • Cornea
    • Lens
    • Retina
  • R&D
    • Research Domains
    • Agreements and licences/Our patents
  • INTERNATIONAL
    • Export a strategic pillar
    • Horus pharma around the world and our subsidiaries
  • CAREERS
    • Horus' Spirit / Our Business
    • Recruitment
  • NETWORK OF EXPERTS
  • NEWS AND AGENDAS
    • News
  • PRESS
  • Webinars
    • Gestion de cabinet d'ophtalmologie
  • CONTACT
Menu
  • Home
  • About
  • +
    Products
    • +
      Ophthalmology
      • Allergy
      • Healing
      • Glaucome
      • Herpes
      • Infection
      • Sore
      • Corneal edema
      • Diabetic macular edema
      • Tissue regeneration
      • Ocular dryness
    • +
      Micronutrition
      • Food supplements
    • +
      Dermatology
      • Blepharitis, meibomian gland dysfonction
    • +
      Contactology
      • Rigid lenses care
      • Soft contact lenses care
    • +
      Surgery
      • Cornea
      • Lens
      • Retina
  • R&D
  • International
  • Careers
  • News
  • Presse
  • Webinars
  • Contact us
> About> Key Figures

KEY FIGURES

HORUS PHARMA

The performance of Horus Pharma is based on a reasoned dynamic of Research and Development, recruitment and international conquest.

Recording two-digit growth since its inception, Horus Pharma ended the year 2019 with a turnover of €64 million. A good progress which is expected to continue with a forecast turnover over €75 million in 2020.

Horus Pharma is currently accelerating its growth by expanding its international business by creating subsidiaries in Europe : Belgium, Spain and the Netherlands. Horus Pharma is also increasing distribution agreements outside Europe.

See our subsidiaries

More than numbers, results

Horus Pharma growth is measured through concrete results in terms of hiring, product portfolio expansion and performance at the national and international levels.

Employment

With a sustained recruitment policy of 10% annual hiring, Horus Pharma has established itself as a thriving SME and employment generator in the Nice area.

Innovation

Innovation takes the form of a sustained rate of product launches, patent filing and expansion of the product portfolio, which includes more than 50 specialities today, to progressively cover all therapeutic segments in ophthalmology.

International

With an international focus since 2010, Horus Pharma has a voluntary Export policy, through the constant expansion of its distribution network, covering 12 countries in Western Europe, North America and Asia including Russia. This dynamic of extension is coupled with the launch of the first European subsidiaries in 2015.

X 2

In the span of 4 years between 2013 and 2017, the number of Horus Pharma employees has doubled growing to nearly 150 employees today.

> 50

At the rate of 3 to 4 new product launches per year, the laboratory's product portfolio has expanded to bring together some fifty specialties.

97ÈME

The position Horus Pharma holds in the National Ranking for SMEs and most successful independent French ETI

Edition  2014 of the L'Express National Ranking

See our areas of research


Horus Pharma

Categories

  • Ophthalmology
    • Allergy
    • Healing
    • Glaucome
    • Herpes
    • Infection
    • Sore
    • Corneal edema
    • Diabetic macular edema
    • Tissue regeneration
    • Ocular dryness
  • Micronutrition
    • Food supplements
  • Dermatology
    • Blepharitis, meibomian gland dysfonction
  • Contactology
    • Rigid lenses care
    • Soft contact lenses care
  • Surgery
    • Cornea
    • Lens
    • Retina

Information

  • Personal Data Protection Policy
  • LEGAL NOTICE
  • General Sales Conditions
  • About
  • products
  • R&D
  • International
  • Careers
  • News
  • Presse

Store Information

  • Horus Pharma
    148 avenue Guynemer, Cap Var
    06700 Saint-Laurent du Var
  • 04 93 19 54 03
  • contact@horus-pharma.fr

Follow us

  • Facebook
  • Youtube
  • Pinterest
Agence Web LyonDev

© 2018-2020 - Site réalisé et hébergé par LyonDev - EURL JUML69 - 88 Grande Rue 69340 Francheville - FRANCE